AAM
Auxier Asset Management Portfolio holdings
AUM
$681M
This Quarter Return
+5.69%
1 Year Return
+17.77%
3 Year Return
+52.05%
5 Year Return
+114.92%
10 Year Return
+221.88%
AUM
$603M
AUM Growth
+$603M
(+3.7%)
Cap. Flow
-$7.41M
Cap. Flow
% of AUM
-1.23%
Top 10 Holdings %
Top 10 Hldgs %
32.84%
Holding
165
New
3
Increased
15
Reduced
98
Closed
1
Top Buys
| 1 |
Alibaba
BABA
|
$1.52M |
| 2 |
Organon & Co
OGN
|
$637K |
| 3 |
DISCA
Discovery, Inc. Series A Common Stock
DISCA
|
$261K |
| 4 |
British American Tobacco
BTI
|
$238K |
| 5 |
Charter Communications
CHTR
|
$218K |
Top Sells
| 1 |
PepsiCo
PEP
|
$2.2M |
| 2 |
Mastercard
MA
|
$1.05M |
| 3 |
Johnson & Johnson
JNJ
|
$655K |
| 4 |
Procter & Gamble
PG
|
$507K |
| 5 |
Coca-Cola
KO
|
$413K |
Sector Composition
| 1 | Healthcare | 26.85% |
| 2 | Financials | 18.14% |
| 3 | Consumer Staples | 17.19% |
| 4 | Technology | 10.31% |
| 5 | Consumer Discretionary | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Illinois Tool Works
ITW
$76.4B
| $247K | 0.04% |
1,104
-17
| -2% | -$3.8K |
|
152
Align Technology
ALGN
$9.95B
| $244K | 0.04% |
400
| – | – |
|
|
DISCK
153
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $238K | 0.04% |
8,211
| – | – |
|
|
154
Charter Communications
CHTR
$36B
| $218K | 0.04% |
+302
| New | +$218K |
|
155
Compass Minerals
CMP
$792M
| $215K | 0.04% |
3,620
| – | – |
|
156
Enbridge
ENB
$105B
| $213K | 0.04% |
5,330
-393
| -7% | -$15.7K |
|
157
Fox Class A
FOXA
$27.1B
| $209K | 0.03% |
5,619
-4
| -0.1% | -$149 |
|
158
Ford
F
$46.4B
| $193K | 0.03% |
12,982
+1,500
| +13% | +$22.3K |
|
|
GMRE
159
Global Medical REIT
GMRE
$489M
| $177K | 0.03% |
+12,000
| New | +$177K |
|
160
Hewlett Packard
HPE
$29.6B
| $172K | 0.03% |
11,821
-500
| -4% | -$7.28K |
|
161
Viatris
VTRS
$12.3B
| $150K | 0.02% |
10,500
-213
| -2% | -$3.04K |
|
162
Nokia
NOK
$22.9B
| $86K | 0.01% |
16,157
-880
| -5% | -$4.68K |
|
163
Lloyds Banking Group
LYG
$63.1B
| $42K | 0.01% |
16,500
| – | – |
|
164
Perspective Therapeutics
CATX
$247M
| $11K | ﹤0.01% |
14,218
| – | – |
|